Medical Device CEO Charged in COVID-19 Test Fraud Scheme

Published: Jan. 15, 2021, 8 p.m.

Keith Berman, 67, is the CEO of Decision Diagnostics, a medical device company based in Westlake Village, CA. On Friday, the Department of Justice announced that a federal grand jury indicted Berman in connection with an alleged scheme to defraud investors. Berman allegedly made false and misleading statements about a new COVID-19 test, which led to millions of dollars in investor losses.

Download and listen to the audio version below and click here to subscribe to the Today in Manufacturing podcast.